Navigation Links
Isis Pharmaceuticals Earns $2 Million from GSK for the Advancement of ISIS-TTR Rx
Date:7/30/2013

novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 28 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer.  Isis' partner, Genzyme, is commercializing Isis' lead product, KYNAMRO™, in the United States for the treatment of patients with HoFH.  Genzyme is also pursuing marketing approval of KYNAMRO in other markets.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at www.isispharm.com.

ISIS PHARMACEUTICALS' FORWARD-LOOKING STATEMENT
This press release includes forward-looking statements regarding Isis' strategic alliance with GlaxoSmithKline, and the discovery, development, activity, therapeutic and commercial potential and safety of ISIS-TTRRx.  Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs, including the commercial potential of KYNAMRO, is a forward-looking statement and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs.  Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements.  Although Isis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Isis.  As a result, you are cautioned not to rely on these forward-looking statements.  These a
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 7, 2015 Noting the need ... pricing policies currently practiced by the rapidly consolidating pharmacy ... (SCPC) today praised Ohio Governor ... a new state effort to help pull back the ... "We applaud Governor Kasich for bringing badly-needed ...
(Date:7/7/2015)... , July 7, 2015 Biobanks ... Helping Your Influence  ,Are you interested ... so, now gain technological and commercial predictions from 2015. ... explore trends in research and development, results, opportunities and ... visiongain shows you what,s possible for biobanking and ...
(Date:7/7/2015)... , 7. Juli 2015 ... -Technik für klinische Studien, gab heute bekannt, dass ... führendes Unternehmen bei Gewinnung und Erhalt von Patienten ... Tochtergesellschaften MediciGlobal , Ltd. und Access to ... auch einen Dienst zum Auffinden von Patienten, die ...
Breaking Medicine Technology:National LTC Pharmacy Leader Praises Kasich Effort to Bring Transparency to PBM Drug Pricing 2National LTC Pharmacy Leader Praises Kasich Effort to Bring Transparency to PBM Drug Pricing 3Biobanking for Medicine: Technology, Industry and Market 2015-2025 2Biobanking for Medicine: Technology, Industry and Market 2015-2025 3Biobanking for Medicine: Technology, Industry and Market 2015-2025 4Biobanking for Medicine: Technology, Industry and Market 2015-2025 5Biobanking for Medicine: Technology, Industry and Market 2015-2025 6Biobanking for Medicine: Technology, Industry and Market 2015-2025 7Biobanking for Medicine: Technology, Industry and Market 2015-2025 8Biobanking for Medicine: Technology, Industry and Market 2015-2025 9Biobanking for Medicine: Technology, Industry and Market 2015-2025 10BioClinica übernimmt MediciGroup 2BioClinica übernimmt MediciGroup 3BioClinica übernimmt MediciGroup 4
... Held at 9:00 a.m. Eastern Time Today, May 26, ... (Nasdaq: UTHR ) announced today that the ... ADCIRCA(TM) (tadalafil) tablets for oral administration, with a recommended ... type 5 (PDE5) inhibitor for the treatment of pulmonary ...
... 23 Amid all the speculation over what course ... Replikins Ltd. ( www.replikins.com ) last week ... and determined that the infectivity of the H1N1 virus ... low for the immediate future.The company,s quantitative analysis of ...
Cached Medicine Technology:FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 2FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 3FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 4Swine Flu (H1N1) Infectivity to Increase Markedly and Lethality to Remain Low According to Latest Replikin* Peptide Genomic Data 2
(Date:7/7/2015)... ... July 07, 2015 , ... ... Southwest, including Giant, Mustang, Sun Dial and Howdy’s, raised more than $524,286 ... 2015 fundraising goal by nearly $100,000, to help support children fighting muscular ...
(Date:7/7/2015)... ... July 07, 2015 , ... Difass USA, a modern supplement brand committed ... stressful days at work is knowing that there is hopefully a vacation to look ... free as imagined. Planning for a vacation can be quite stressful, and it’s difficult ...
(Date:7/7/2015)... ... July 07, 2015 , ... This week Northeast ... brand new website. The website’s goal is to provide patients with detailed information ... tools, including requesting appointments online. , Part of the center’s rebranding efforts, the ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... Consulting announced today that the two firms have merged to form Camber ... health and biopharma sectors. The merger combines SwitchPoint’s strategy consulting expertise with ...
(Date:7/7/2015)... ... 2015 , ... Greatist today announced the acquisition of Blood, ... the most fun activities to do with friends. , The acquisition of BSC strengthens ... opportunity for events, e-commerce, and brand partnerships. , “I’ve been a huge fan of ...
Breaking Medicine News(10 mins):Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 3Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3Health News:Northeast Nebraska Imaging Launches New Patient Friendly Website 2Health News:SwitchPoint and Hope Consulting Have Merged to Form Camber Collective 2Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2
... 19 Studies have shown wearing a helmet while riding a ... yet every three days, a child in the United States is ... children are treated in emergency rooms due to bicycle-related head injuries. ... of Michigan C.S. Mott Children,s Hospital National Poll on Children,s ...
... in patients , FRIDAY, June 19 (HealthDay News) -- ... explain brain gray matter reductions experienced by patients with ... an association between fibromyalgia and reductions in gray matter, ... In this new study, Dr. Patrick B. Wood, of ...
... of E. coli infection in 28 states , ... warning consumers not to eat any Nestlé Toll House refrigerated ... coli contamination. , In response to the Food and ... voluntarily recalling its Toll House refrigerated cookie dough items. , ...
... 19 Warner Chilcott Limited (Nasdaq: WCRX ) ... Mid-Year Equity Conference on Wednesday, June 24, 2009 at 2:30 ... Fuhrmann, Senior Director, Investor Relations. , , Warner Chilcott,s ... www.wcrx.com under the Investor Relations tab. An ...
... , Brio Active opens its doors this month, offering a ... its core. , , DENVER, June 19 Brio ... vibration, a relatively new fitness concept in the U.S., with ... strength, flexibility, balance, energy, bone density, and neuromuscular coordination. ...
... ... ... - Last week, the World Health Organization declared the H1N1 virus, also commonly referred to ... urging healthcare providers to take precautions to limit the spread of the virus from infected ...
Cached Medicine News:Health News:Bicycle Helmet Laws For Kids Effective But Not Yet the Norm 2Health News:Bicycle Helmet Laws For Kids Effective But Not Yet the Norm 3Health News:Bicycle Helmet Laws For Kids Effective But Not Yet the Norm 4Health News:Nestlé Recalls Raw Cookie Dough Products 2Health News:Brio Active Brings Whole Body Vibration Fitness to Cherry Hills Village 2Health News:Real-Time Locating Technology Helps Contain Pandemic Outbreaks 2Health News:Real-Time Locating Technology Helps Contain Pandemic Outbreaks 3Health News:Real-Time Locating Technology Helps Contain Pandemic Outbreaks 4
IOL choppers for positioning intraocular lenses. Blunt tip avoids damage to intraocular lenses. For .20mm diameter holes and larger....
...
...
...
Medicine Products: